Skip to main content
Log in

Current Status of Disease-Modifying Drugs in Progressive Rheumatoid Arthritis

  • Leading Aritcle
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Bandilla, K.; Gross, D.; Gross, W.; Herrlinger, J.-D.; Kriegel, W.; Müller, W.; Siegmeth, W.; Tausch, G.; Thumb, N. and Wagenhäuser, F.J.: Oral gold therapy with auranofin (SK&F 39162). Journal of Rheumatology 9 (Suppl. 8): 154–159 (1982).

    Google Scholar 

  • Barraclough, D.; Brook, A.; Brooks, P.; Boyden, K.; Thomas, D. and Tymms, K.: Auranofin, gold sodium thiomalate, and d-penicillamine in rheumatoid arthritis: A progress report. Journal of Rheumatology 9 (Suppl. 8): 197–200 (1982).

    Google Scholar 

  • Bernhard, G.C.: Auranofin treatment for adult rheumatoid arthritis. Journal of Rheumatology 9 (Suppl. 8): 149–153 (1982).

    Google Scholar 

  • Blodgett Jr, R.C.: Auranofin symposium–an epilogue. Journal of Rheumatology 9 (Suppl. 8): 207–208 (1982).

    Google Scholar 

  • Bunch, T.W. and O’Duffy, J.D.: Disease-modifying drugs for progressive rheumatoid arthritis. Mayo Clinic Proceedings 55: 161–179 (1980).

    PubMed  CAS  Google Scholar 

  • Bunch, T.W.; O’Duffy, J.D.; Tompkins, R.B. and O’Fallon, W.M.: Controlled trial of hydroxychloroquine and penicillamine singly and in combination in treatment of rheumatoid arthritis. Arthritis and Rheumatism (In press, 1984).

    Google Scholar 

  • Champion, G.D.; Bieri, D.; Browne, C.D.; Day, R.O.; Graham, G.G.; Haavisto, T.M.; Sambrook, P.N. and Vallance, J.B.: Auranofin in rheumatoid arthritis. Journal of Rheumatology 9 (Suppl. 8): 137–145 (1982).

    Google Scholar 

  • Cooperating Clinics Committee of the American Rheumatism Association: A controlled trial of cyclophosphamide in rheumatoid arthritis. New England Journal of Medicine 283: 883–889 (1970).

    Article  Google Scholar 

  • Decker, J.L.: Apheresis and rheumatoid arthritis. Annals of Internal Medicine 98: 666–667 (1983).

    PubMed  CAS  Google Scholar 

  • Finkelstein, A.E.; Roisman, R.F.; Ladizesky, M.G. and Walz, D.T.. Auranofin and lysosomal enzymes. Journal of Rheumatology 9 (Suppl. 8): 46–53 (1982).

    Google Scholar 

  • Furst, D.E.; Landow, E.M.; Dromgoole, S.H.; Blocka, K. and Paulus, H.E.: Pharmacokinetics of auranofin after single and multiple dosing. Clinical Pharmacology and Therapeutics 31: 227 (1982).

    Google Scholar 

  • Gofton, J.P. and O’Brien, W.M.: Effects of auranofin on the radiological progression of joint erosion in rheumatoid arthritis. Journal of Rheumatology 9 (Suppl. 8): 169–172 (1982).

    Google Scholar 

  • Herrlinger, J.D.; Alsen, C.; Beress, R.; Hecker, V. and Weikert, W.: Distribution of gold in serum erythrocytes and white blood cells after in vitro incubation and during chrysotherapy with different gold compounds. Journal of Rheumatology 9 (Suppl. 8): 81–89 (1982).

    Google Scholar 

  • Heuer, M. and Morris, R.: Smith, Kline & French worldwide clinical experience with auranofin: A review (Excerpta Medica, Amsterdam 1983).

    Google Scholar 

  • Hochberg, M.C.: Long-term double-blind study of auranofin and D-penicillamine in the treatment of rheumatoid arthritis. (In progress.) Personal communication (1984).

    Google Scholar 

  • Iannuzzi, L.; Dawson, N.; Zein, N. and Kushner, I.: Does drug therapy slow radiographic deterioration in rheumatoid arthritis? New England Journal of Medicine 309: 1023–1028 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Jaffe, I.A.: Intra-articular dissociation of the rheumatoid factor. Journal of Laboratory and Clinical Medicine 60: 409–421 (1962).

    PubMed  CAS  Google Scholar 

  • Katz, W.A.; Alexander, S.; Bland, J.H.; Blechman, W.; Bluhm, G.B.; Bonebrake, R.A.; Falbo, A.; Greenwald, R.A.; Hartman, S.; Hobbs, T.; Indenbaum, S.; Lergier, J.E.; Lanier, B.G.; Lightfoot, R.W.; Phelps, P.; Sheon, R.P.; Torretti, D.; Wenger, M.E. and Wilske, K.: The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis. Journal of Rheumatology 9 (Suppl. 8): 173–178 (1982).

    Google Scholar 

  • Lipsky, P.E.: Remission-inducing therapy in rheumatoid arthritis. Proceedings of a Symposium: Management of Rheumatoid Arthritis and Osteoarthritis. American Journal of Medicine (Suppl., Oct. 31): 40–49 (1983).

    Google Scholar 

  • Luthra, H.S.; Dillon, A.M.; Bunch, T.W.; O’Duffy, J.D.; Conn, D.L. and O’Fallon, W.M.: Comparison of auranofin and D-penicillamine in the treatment of progressive rheumatoid arthritis. (In progress, 1984).

    Google Scholar 

  • McCarty, D.J. and Carrera, G.F.: Intractable rheumatoid arthritis: Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine. Journal of the American Medical Association 248: 1718–1723 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Menard, H.A.; Beaudet, F.; Davis, P.; Harth, M.; Percy, J.S.; Russell, A.S. and Thompson, J.M.: Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin. Journal of Rheumatology 9 (Suppl. 8): 179–183 (1982).

    Google Scholar 

  • Multicenter Trial Group: Controlled trial of D-penicillamine in severe rheumatoid arthritis. Lancet 1: 275–280 (1983).

    Google Scholar 

  • O’Brien, W.M.: Pharmacology of nonsteroidal anti-inflammatory drugs: Practical review for clinicians. Proceedings of a Symposium: Management of Rheumatoid Arthritis and Osteoarthritis. American Journal of Medicine (Suppl., Oct. 31): 32–39 (1983).

    Google Scholar 

  • Page, F.: Treatment of lupus erythematosus with mepacrine. Lancet 2: 755–758 (1951).

    Article  PubMed  CAS  Google Scholar 

  • Pinals, R.S.: Approaches to rheumatoid arthritis and osteoarthritis: An overview. Proceedings of a Symposium: Management of Rheumatoid Arthritis and Osteoarthritis. American Journal of Medicine (Suppl., Oct. 31): 2–9 (1983).

    Google Scholar 

  • Pinals, R.S.; Masi, A.T.; Larson, R.A. and the Subcomittee for Criteria of Remission in Rheumatoid Arthritis of the American Association Diagnostic and Therapeutic Criteria Committee: Arthritis. Arthritis and Rheumatism 24: 1308–1315 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Rothermich, N.O.; Thomas, M.H.; Phillips, V.K. and Bergan, W.: Clinical trial of penicillamine in rheumatoid arthritis. Arthritis and Rheumatism 24: 1473–1478 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Rothermich, N.O.; Phillips, V.K.; Bergan, W. and Thomas, M.H.: Follow-up study of chrysotherapy. Arthritis and Rheumatism 22: 423 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Runge, L.A.: Risk/benefit analysis of hydroxychloroquine sulfate treatment in rheumatoid arthritis: Proceedings of a Symposium: A Reassessment of Plaquenil in the Treatment of Rheumatoid Arthritis. American Journal of Medicine (Suppl., Oct. 31): 52–56 (1983).

    Google Scholar 

  • Rynes, R.I.: Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment. Proceedings of a Symposium: A Reassessment of Plaquenil in the Treatment of Rheumatoid Arthritis. American Journal of Medicine (Suppl., Jul. 18): 35–39 (1983).

    Google Scholar 

  • Salmeron, G. and Lipsky, P.E.: Modulation of human immune responsiveness in vitro by auranofin. Journal of Rheumatology 9 (Suppl. 8): 25–31 (1982).

    Google Scholar 

  • Schattenkirchner, M.; Kaik, B.; Mulier-Fassbender, H.; Rau, R. and Zeidler, H.: Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study. Journal of Rheumatology 9 (Suppl. 8): 184–189 (1982).

    Google Scholar 

  • Schorn, D.: An oral gold formulation in RA. South African Medical Journal 62: 313–316 (1982).

    PubMed  CAS  Google Scholar 

  • Smith, P.R.; Brown, G.M.M. and Meyers, O.L.: An open comparative study of auranofin versus gold sodium thiomalate. Journal of Rheumatology 9 (Suppl. 8): 197–200 (1982).

    Google Scholar 

  • Walz, D.T.; Di Martino, M.J. and Griswold, D.E.: Comparative pharmacology and biological effects of different gold compounds. Journal of Rheumatology 9 (Suppl. 8): 54–60 (1982a).

    Google Scholar 

  • Walz, D.T.; Di Martino, M.J. and Griswold, D.E.: Mechanisms of action of auranofin: Effects of humoral immune response. Journal of Rheumatology 9 (Suppl. 8): 32–36 (1982b).

    Google Scholar 

  • Ward, J.R.; Williams, H.J.; Egger, M.J.; Reading, J.C.; Boyce, E.; Altz-Smith, M.; Samuelson, C.O.; Willkens, R.F.; Solsky, M.A.; Hayes, S.P.; Blocka, K.L.; Weinstein, A.; Meenan, R.F.; Guttadauria, M.; Kaplan, S.B. and Kippel, J.: Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Arthritis and Rheumatism 26: 1303–1315 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Weisman, M.H.; Hannifin, D.M.; Guerra Jr, J.; Resnik, C. and Rcsnick, D.: Analysis of auranofin as a rheumatoid remitting agent. Journal of Rheumatology 9 (Suppl. 8): 132–136 (1982).

    Google Scholar 

  • Willkens, R.F.: Reappraisal of the use of methotrexate in rheumatic disease. Proceedings of a Symposium: Management of Rheumatoid Arthritis and Osteoarthritis. American Journal of Medicine (Suppl., Oct. 31): 19–25 (1983).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

O’Duffy, J.D., Luthra, H.S. Current Status of Disease-Modifying Drugs in Progressive Rheumatoid Arthritis. Drugs 27, 373–377 (1984). https://doi.org/10.2165/00003495-198427050-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198427050-00001

Keywords

Navigation